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Background: Health-related quality of life (HRQL) has been increasingly used as an outcome
measure in asthma, but less is known about the prognostic implication of low health-related
quality of life. The purpose of this study was to investigate if a set of quality of life measures
could predict onset of asthma.
Methods: In the baseline study 391 subjects without asthma answered a respiratory question-
naire and the Gothenburg Quality of Life (GQL) instrument in 1990. The GQL questionnaire
included two parts: (1) the prevalence of HRQL-related symptoms and (2) well-being scores
for physical, mental and social dimensions. The participants were also investigated with
spirometry and allergy testing. In 2003, the same respiratory questionnaire that had been used
in 1990 was sent. There were 290 responders, of whom 22 subjects had developed asthma.
Results: Participants who had developed asthma by the follow-up had a higher prevalence of
sleep disturbances (30% vs. 10%), problems with chest pain (16% vs. 2%), depression (40% vs.
20%) difficulty relaxing (40% vs. 13%) and constipation (25% vs. 2%) at baseline than participants
who did not develop asthma (p< 0.05). Subjects who developed asthma also scored signifi-
cantly lower on well-being variables as sleep, energy, mood, patience, memory, appetite,
fitness and sense of appreciation outside home. These differences remained after adjusting
for age, sex, smoking habits, asthma heredity, socioeconomic groups and building dampness.
Conclusion: Participants with low health-related quality of life at baseline were more likely to
report having developed asthma 12 years later.
ª 2008 Elsevier Ltd. All rights reserved.niversity Collage, Department of Health Care Science, P.O. Box 11189, SE-100 61 Stockholm, Sweden.
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Health-related quality of life (HRQL) assessment as
a measure of clinical and therapeutic outcome has been
increasingly used as an outcome measure in chronic respi-
ratory disease, especially in asthma. In contrast to
conventional indicators of the disease and its objective
outcomes, HRQL focuses on the patients’ own assess-
ments.1 Both disease-specific2 and generic measures3 of
HRQL have been developed to quantify the experience
individuals have with their health.
The prevalence of asthma has increased worldwide4 and
with the increased prevalence of asthma in the western
world, it is of great importance to describe factors that
contribute to the onset of the disease in order to make it
possible to identify assessments to promote health and
accordingly minimize the human suffering due to asthma.
Furthermore, finding risk factors that may be influential
could lead to reducing the financial burden that the disease
of asthma accounts for in today’s society.5
A longitudinal study on asthma prevalence and incidence
was performed in two counties of Sweden in 1990e2003.6
The Gothenburg Quality of Life Instrument (GQL) was
included in the 1990 measurement.7 The GQL is a generic
measure that has been used in previous studies when, for
example, estimating the impact of different health-related
risk factors on the onset of cardiovascular disease,8 dia-
betes, and Sjo¨gren’s syndrome.9,10 Several studies have
shown that a low HRQL is related to increased risk of
mortality, hospitalization and emergency department
utilization in patients with asthma and chronic obstructive
pulmonary disease.11e13 In the present study the hypothesis
was that a low health-related quality of life is related to
asthma onset.
Material and methods
This is a longitudinal study with an epidemiological design
including a baselinemeasure in 1990 and a follow-up in 2003.
Study area
This study includes participants from two counties in Swe-
den, Ja¨mtland and Ga¨vleborg. The total area of Ja¨mtland is
approximately 30 000 km2. The western part, bordering
Norway, is mountainous, while the central and eastern
parts contain more farming areas, forests and water-
courses. Ja¨mtland’s climate is cold, with a mean January
temperature of 8 to 15 C in January and a mean July
temperature varying from 12 to 15 C. Ga¨vleborg is situated
on the Baltic coast at low altitude and covers 4200 km2. The
mean temperature in January is 5 C and the mean July
temperature 17 C.
Study sample
In the 1990 baseline study, subjects were selected from the
responders to a postal respiratory questionnaire sent to
three different age groups: all individuals aged 16 years, and
a random selection of the age groups of 30e39 years and 60e
69 years, aiming at reaching 13% of each group. In Ja¨mtland6149 and in Ga¨vleborg 6583 individuals were included. A
total of 11 294 subjects (89%) answered the questionnaire.14
In a second phase all subjects who reported a history of
asthma, chronic bronchitis or respiratory symptoms were
invited for a clinical investigation including spirometry,
allergy testing and assessment of HRQL using the GQL
questionnaire. In addition a random selection of 600
subjects without a history of respiratory diseases and
respiratory symptoms were also invited to this phase of the
investigation.6 The present analysis is based on the 391
subjects without respiratory symptoms that completed the
GQL questionnaire (Fig. 1). Of these 86 were excluded as
the clinical investigation indicated a presence of asthma or
other lung disease.
In 2003, 290 of the 391 subjects without respiratory
diseases or symptoms at baseline completed a postal
respiratory questionnaire with similar questions as in 1990
(Fig. 1). In addition, there was a question on occupation in
2003, that was used for socioeconomic grouping.
Measurements
Respiratory questionnaire 1990 and 2003
The respiratory questionnaire used was based on the British
Medical Research Council questionnaire, later modified and
used in earlier studies in northern Sweden.15,16 The ques-
tionnaire consists of 22 items including questions on:
previous history of asthma or chronic bronchitis; use of
anti-asthmatic medication; physician’s diagnosis of asthma,
chronic bronchitis, or emphysema; attacks of dyspnoea,
shortness of breath or breathlessness; wheezing in the
chest; and prolonged productive cough and smoking.
Health-related quality of life 1990
To assess subjective well being, the Gothenburg Quality of
Life instrument (GQL) was used.7 The instrument was con-
structed as early as 1972 and is based on the definition of
health by WHO. Part one of the instrument covers 30
common symptoms answered by ‘yes’ or ‘no’ to questions
on whether the respondents had experienced any of the
symptoms during the last 3 months. Part two of the
instrument includes 18 items covering subjective physical,
mental and social well being. The respondent is to answer
each item on a seven-step Likert scale ranging from ‘very
bad’ (Z 1) to ‘excellent/could not be better’ (Z 7) thus
a high score indicates a better HRQL. GQL has been vali-
dated using a Swedish sample.7
Clinical measurements 1990
The clinical measurement consists of spirometry, allergy
testing and recording of PEF variability.
Lung function was tested with pneumotachographs
(Vitalograph Alpha, London, England). Vital capacity (VC)
and forced expiratory volume in 1 s (FEV1) were tested. The
ATS (American Thoracic Society 1987) recommendations for
spirometric testing were followed, except that the Vitalo-
graphs were calibrated once daily with a 1-L syringe, as
suggested by the ATS. Diagnoses were based on the criteria
suggested by the ATS.17
A skin prick test was performed using Phazet (Pharmacia
Diagnostics, Uppsala, Sweden), which are stainless lancets
Figure 1 Selection of the responders and the final study sample.
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common allergens.19 Lancets with allergen were applied on
the skin inside the forearm. A skin test was said to be positive
if the mean wheal diameter was greater than 3 mm.
Socioeconomic grouping 2003
Reports of the respondents’ current occupations were
divided into five socioeconomic groups: (1) managers and
professionals (i.e. legislators, senior officials, managers
and professionals); (2) other non-manual (i.e. technicians
and associate professionals, clerks, service workers and
market sales workers); (3) skilled manual (i.e. skilled agri-
cultural and fishery workers and craft and related trades
workers); (4) semi-skilled or unskilled manual (i.e. plant
and machine operators and assemblers and elementary
occupations); and (5) unclassifiable or unknown (i.e.
housewife, student, not classifiable job, unemployed, not
working because of poor health, and retired). A Swedish
classification of occupations based on the International
Standard Classification of Occupations (ISCO-88) and the
European Union variant of ISCO-88 was used.21
Definitions
Definition of asthma
From the respiratory questionnaire in the follow-up 2003
four questions were chosen in order to estimate onset ofasthma. These are: Have you had or do you have asthma?
Has your doctor diagnosed asthma? Do you use any asthma
medicine? and Do you have or have you had asthma symp-
toms (attack of difficulty breathing or breathlessness, with
or without cough, with or without wheeze in the chest).
The respondents were judged to have had an onset of
asthma if they answered yes to one or more of these
questions concerning asthma.
Definition asthma heredity
Participants answering ‘‘yes’’ to the question: ‘‘Do your
parents, sibling or children have asthma?’’ in 1990 are
referred to as having asthma heredity.
Statistical analysis
The SPSS 14.0 software program was used for statistical
analyses. The Chi-squared test was used to compare the
prevalence of GQL symptoms, and the ManneWhitney U-test
to compare GQL symptom scores in participants who
developed or did not develop asthma during the follow-up
period. The association between asthma onset and clinical
measures was tested for with an unpaired t-test. Multivar-
iate logistic regression was used to test if the association
between GQL symptoms and asthma onset remained stati-
cally significant after adjusting for potential confounders:
age, sex, smoking habits, asthma heredity, and socioeco-
nomic groups and building dampness in home.20
Table 1 Characteristics of the study sample, 1990 and 2003 (nZ 290).
1990 No asthma (nZ 22) Asthma (nZ 268) p-Value
Women % 51 54 0.732
Age %
All 16 years 28 45 0.104
30e39 45 45
60e69 27 9
Asthma heredity % 12 36 <0.005
Spirometry, mean SD
FEV1 percent predicted 102 14 96 15 0.085
VC percent predicted 102 14 104 19 0.443
PEF variability percent of the mean
Skin prick test positive % 27 39 0.911
Smoking habits %
Non-smokers 59 55 0.699
Ex-smokers 29 32
Smokers 12 14
2003
Damp dwelling % 9 0 0.150
Socioeconomic group %
Managers and professionals 11 9 0.826
Other non-manual 51 64
Skilled manual 10 9
Semi-skilled or unskilled manual 19 14
Unclassifiable or unknown 9 5
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The study was approved by Ethics Committee at the
University of Umea˚ (x 222, 1989-12-12) and the Ethics
Committee, Faculty of Medicine, Uppsala (Dnr. 01-313).
Results
Twenty-two subjects had developed asthma during the
follow-up period (Fig. 1). Subjects who had developed
asthma had more asthma in the family compared to non-
asthmatic subjects, but otherwise no significant differences
were found between the groups regarding baseline char-
acteristics (Table 1).
The prevalence of HRQL symptoms in subjects who
developed or did not develop asthma is presented in the
polar diagram (Fig. 2). Participants who had developed
asthma by the follow-up study had a higher prevalence of
most of the HRQL symptoms. A statically significant
difference between those who developed asthma and those
who did not was found for sleep disturbances, chest pain,
difficulty relaxing, depression and constipation. This
difference remained statically significant after adjusting
for age, sex, smoking habits, asthma heredity, socioeco-
nomic groups and building dampness.
The results of the GQL well-being scale are presented in
Table 2. As seen, the asthma group rated their mental well
being as being poorer than the non-asthma group. Further,
there was a statistically significant difference between the
groups concerning fitness, memory, appetite and ‘sense of
appreciation outside home’. These differences remainedstatically significant after adjusting for age, sex, smoking
habits, asthma heredity, socioeconomic groups and building
dampness.
Analysis of the non-responders
Non-responders (nZ 68) were more likely to belong to the
youngest age group (56% vs. 30%, p< 0.001) than subjects
who answered the follow-up questionnaire. No significant
differences were found regarding sex, smoking habits,
asthma heredity, atopy, respiratory symptoms and spirom-
etry results. Non-responders reported significantly less
general fatigue (21% vs. 35%, p< 0.05) than responders
were as no significant differences were found regarding the
GQL well-being scale.Discussion
In this longitudinal study of quality of life, several symp-
toms such as sleep disturbances, difficulty to relax and
chest pain were significantly increased in subjects who
subsequently developed asthma. The subjects who devel-
oped asthma during the study period also scored signifi-
cantly lower on several well-being variables at baseline.
This indicates that early undiagnosed or pre-clinical asthma
affects quality of life or that poor quality of life makes it
more likely that a diagnosis of asthma is made. An alter-
native explanation is that low quality of life is an inde-
pendent predictor of asthma onset.
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Figure 2 The prevalence of HRQL symptoms. The grey area represents the prevalence of symptoms in subjects with asthma onset
since 1990 and the black line the prevalence in non-asthmatic subjects. Differences that remained significant after adjustment for
age, sex, smoking habits, asthma heredity, home dampness and socioeconomic factors are marked with stars and surrounded by
a line. *p 0.05, **p 0.01, ***p 0.001.
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subjects who developed asthma during the study period.
Previous studies have shown that sleep disturbances,
awakenings and daytime sleepiness are common among
patients with asthma.22 This is also in line with findings that
inadequately controlled allergic rhinitis18 is related to
impaired sleep since asthma and rhinitis often coexists.
Another possible explanation may be that nocturnal gastro-
oesophageal reflux which is common in asthma23 is
a predictor of low quality of sleep.24 It has also been
proposed that occult obstructive sleep apnoea is a more
common cause of sleepiness in asthmatics than asthma
itself.22 Poor sleep has a detrimental impact on daily
functioning and quality of life even in healthy people. Sleep
disturbances make people more susceptible to cognitive
impairment such as poor memory decreased learning abil-
ities and weakened concentration. Also, psychological
consequences such as fatigue, irritability, anxiety and
depression are present in such situations.27
Symptoms including depression, difficult to relax, diffi-
cult in passing urine, constipation, and loss of weight was
also significantly more prevalent in subjects who developed
asthma. There are several studies showing relationships
between depression, anxiety and insomnia.25 These results
are also in accordance with other studies showing that
depressive symptoms are common in adults with asthma
and are associated with poorer health outcome.27
Furthermore, there appears to be a high comorbidity ofanxiety disorders in patients with asthma.26,33,34 Whether
these psychological aspects precede onset of asthma or are
a consequence of living with asthma, the main objectives of
health care should be to give support aimed at preserving
a satisfactory level of HRQL. Further HRQL should be taken
into account as part of the clinical evaluation in asthmatics.
Individuals who developed asthma scored significantly
lower on several well-being variables, than subjects who
remained free of asthma. This negative effect on well being
may be consequence of living with undiagnosed asthma.
Alternatively these well-being variables might be related to
stress. Environmental stressors may impact asthma
morbidity through neuro-immunological mechanisms,
which are adversely impacted and/or buffered by social
network, social support and psychological functioning.29
The impact of stress on airflow in asthmatics is, however,
unclear.30 The use of coping and differences coping style
may be a valuable tool in handling stress and asthma.28,31 In
the Lazarus transactional model of stress, when facing
a stressful situation each individual sets up specific
adjustment strategies called coping styles.32 This includes
a meaningful pattern of cognitive, behavioural, emotional
and physical responses. The use of active coping styles can
perhaps be valuable in handling stress and asthma. This
hypothesis remains to be tested. Nevertheless, with indi-
viduals at risk for asthma, health care providers can teach
and support them in health behaviours, stress management
and coping in order to improve health.
Table 2 Well-being score in subjects who did not or did develop asthma during the follow-up period 2003. The adjusted p-
value was calculated by multivariate logistic regression of GQL well-being scale in the sample 2003 (nZ 290).
No asthma, nZ 268,
mean SD
Asthma, nZ 22,
mean SD
Adjusted,
p-value
Social well being
Family 6.0 1.1 5.7 1.2 0.122
Housing 6.0 1.1 5.7 1.2 0.661
Work 5.5 1.1 4.6 1.2 0.008
Economy 4.8 1.3 4.9 1.2 0.486
Leisure 5.8 1.1 5.3 1.3 0.054
Sense of appreciation at home 5.5 1.1 4.8 1.0 0.471
Sense of appreciation
outside home
6.0 1.2 5.8 1.5 <0.01
Physical well being
Health 5.9 1.0 5.7 1.0 0.173
Fitness 4.9 1.2 4.2 1.7 <0.05
Memory 5.4 1.2 4.9 1.4 <0.05
Appetite 6.4 0.9 5.9 1.0 <0.05
Vision 5.6 1.4 5.7 1.5 0.922
Hearing 5.9 1.4 6.0 1.4 0.938
Mental well being
Mood 5.7 1.1 5.0 1.0 <0.05
Energy 5.6 1.1 4.8 1.0 <0.005
Patience 5.3 1.3 4.3 1.5 <0.05
Self-confidence 5.3 1.3 4.5 1.4 <0.05
Sleep 6.0 1.3 5.4 1.5 <0.05
p-Values were adjusted for, age, sex, smoking habits, asthma heredity, socioeconomic groups and damp damage.
HRQL predicts onset of asthma 199The strengths of this study are the longitudinal design,
the selection of subject and the validated instrument used
in several studies. It is also strength in that the criteria for
new cases of asthma were carefully defined. The usefulness
of the GQL assessment is determined by the predictive
powers of the variables.7 Further, the GQL instrument has
been used in several studies exploring HRQL in a variety of
health conditions such as diabetes, cardiovascular disease
and Sjo¨gren’s syndrome.9,10 The weakness of this study is
that the group with asthma onset was rather small and that
the GQL measurement was performed only at baseline.
Furthermore asthma onset was only assessed by question-
naire with no clinical validation. The optimal situation
would have been a follow-up with both a clinical exami-
nation and the GQL instrument also in 2003.
Generic measures on health-related quality of life have
been used in a variety of studies to investigate possible
predictive factors.13,35 There is evidence that a generic
measure may be more valuable/valid measure than, for
example, an asthma-specific health-related quality of life
measure in the search for predictive factors.36 On the other
hand, asthma-specific measures are more likely to reflect
small changes in asthma status, providing greater respon-
siveness over time.37 Generic instruments are broader and
reflect the impact of asthma on more global aspects of
functioning and well being.38 Generic instrument has also
been used as a predictive tool in respiratory obstructive
disease.13,12
In conclusion, subjects who developed asthma had
a higher prevalence of HRQL-related symptoms such assleep disturbances, depression, difficulty relaxing and chest
pain and scored significantly lower on several well-being
variables at baseline. This indicates that early undiagnosed
or pre-clinical asthma affects quality of life or that poor
quality of life makes it more likely that a diagnosis of
asthma is made. An alternative explanation is that low
quality of life is an independent predictor of asthma onset.
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